What is Joint Programming?
Joint programming aims to bring a partnership approach and a common vision among EU countries. The aim is to pool national efforts and make better use of national research programmes.
In the health area, two Joint programming initiatives have been established and are supported by the European Commission.
Joint Programming Initiative on Neurodegenerative Diseases Research (JPND)
The JPND is a member-led initiative launched in 2010 whose main purpose is to address the challenge of neurodegenerative diseases through a common research strategy and the alignment of national programmes.
The JPND gathers 28 countries (including non-EU countries such as Canada).
The JPND will make progress in 2 main areas
- mapping and analysing neurodegenerative diseases research activities and resources
- setting a common JPND Strategic Research Agenda
- developing national neurodegenerative diseases research agendas and aligning national plans and strategies
7 joint transnational calls were launched by the JPND between 2011 and 2015. 30 projects are ongoing (2011-2013 calls) and 10 projects have been proposed for support (2014 call). €100 million was committed by JPND members with €10 million co-funding from the EU.
Initiative on Neurodegenerative Diseases Research (JPND)
Joint Programme Initiative on Antimicrobial Resistance (JPIAMR)
Antimicrobial resistance is a global problem that concerns us all The aim of the JPIAMR is to work across national borders, to integrate relevant scientific fields, to implement joint activities and to create a common European research agenda setting out the research priorities.
17 European countries, Canada and Israel are involved in this initiative, leading to an alignment of their research efforts and the funding of transnational research projects.